Drug Shortage Report for OXALIPLATIN INJECTION

Last updated on 2017-04-12 History
Report ID 2606
Drug Identification Number 02436957
Brand name OXALIPLATIN INJECTION
Common or Proper name OXALIPLATIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OXALIPLATIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 40mL fiole/vial
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-01-20
Estimated end date 2017-04-17
Actual end date 2017-04-11
Shortage status Resolved
Updated date 2017-04-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-04-12 English Compare
v6 2017-04-11 French Compare
v5 2017-04-11 English Compare
v4 2017-04-04 French Compare
v3 2017-04-04 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare

Showing 1 to 7 of 7